J
James N. Ingle
Researcher at Mayo Clinic
Publications - 403
Citations - 52917
James N. Ingle is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Breast cancer & Tamoxifen. The author has an hindex of 82, co-authored 387 publications receiving 47883 citations. Previous affiliations of James N. Ingle include McMaster University & University of Rochester.
Papers
More filters
Journal ArticleDOI
Correction to: Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study (Breast Cancer Research, (2017), 19, 1, (130), 10.1186/s13058-017-0920-8)
Jia Yu,Bo Qin,Ann M. Moyer,Jason P. Sinnwell,Kevin J. Thompson,John A. Copland,Laura A. Marlow,James L. Miller,Ping Yin,Bowen Gao,Katherine Minter-Dykhouse,Xiaojia Tang,Sarah A. McLaughlin,Alvaro Moreno-Aspitia,Anthony C. Schweitzer,Yan Lu,Jason Hubbard,Donald Northfelt,Richard Gray,Katie N. Hunt,Amy Lynn Conners,Vera J. Suman,Krishna R. Kalari,James N. Ingle,Zhenkun Lou,Daniel W. Visscher,Richard M. Weinshilboum,Judy C. Boughey,Matthew P. Goetz,Liewei Wang +29 more
Journal Article
Evaluation of mitolactol in women with advanced breast cancer and prior chemotherapy exposure.
Journal ArticleDOI
SMAD5 expression and inhibition of the mitotic kinase aurora-A on sensitivity of breast cancer cells to chemotherapy.
Mateusz Opyrchal,Ianko D. Iankov,James N. Ingle,Jeffrey L. Salisbury,Evanthia Galanis,Antonino B. D'Assoro +5 more
TL;DR: This data indicates that EMT is associated with increased metastatic potential of cancer cells as well as decreased survival in women with high-risk of breast cancer.
Journal ArticleDOI
Multiplex TaqMan assays for a 7-gene prognostic immune response score to differentiate risk among women with ER-negative breast cancer.
John J. Sninsky,Cindy Christopherson,Robert Lagier,Monica Chang,Shirley Kwok,Vickram J. Tandon,Dan H. Moore,Frederic M. Waldman,Amy C. Degnim,James N. Ingle,Christina Yau,Christopher C. Benz,Cheryl Gillett,Andrew Tutt,Alice Wang,Laura J. Esserman +15 more
TL;DR: To facilitate further evaluation of the prognostic value of a classifier in archival fixed tumor tissue, two multiplex TaqMan assays were developed to quantify the expression levels of these genes, then trained and validated a 7-gene immune response score (IRS).